Bone Biologics
(NASDAQ) BBLG
Bone Biologics Financials at a Glance
Market Cap
$2.08M
Revenue (TTM)
$0.00
Net Income (TTM)
$3.11M
EPS (TTM)
$-4.00
P/E Ratio
-0.29
Dividend
$0.00
Beta (Volatility)
0.68 (Low)
Dividend
$0.00
Beta (Volatility)
0.68 (Low)
Price
$1.16
Volume
52
Open
$1.21
Price
$1.16
Volume
52
Open
$1.21
Previous Close
$1.16
Daily Range
$1.16 - $1.21
52-Week Range
$1.11 - $6.75
Dividend
$0.00
Beta (Volatility)
0.68 (Low)
Price
$1.16
Volume
52
Open
$1.21
Previous Close
$1.16
Daily Range
$1.16 - $1.21
52-Week Range
$1.11 - $6.75
BBLG News
BBLG: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Bone Biologics
Industry
Biotechnology
Sector
Health CareEmployees
2
CEO
Jeffrey Frelick, MBA
Website
www.bonebiologics.comHeadquarters
Burlington, MA 01803, US
BBLG Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-70%
Return on Capital
-60%
Return on Assets
-54%
Earnings Yield
-3.45%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.08M
Shares Outstanding
1.80M
Volume
52
Short Interest
0.00%
Avg. Volume
303.96K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$3.23M
EBITDA
$3.11M
Operating Cash Flow
$2.69M
Capital Expenditure
$0.00
Free Cash Flow
$2.69M
Cash & ST Invst.
$5.33M
Total Debt
$0.00
Bone Biologics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$2.08M
N/A
Market Cap/Employee
$1.04M
N/A
Employees
2
N/A
Net Income
$684.64K
+55.0%
EBITDA
$1.39M
+8.5%
Quarterly Fundamentals
Net Cash
$5.33M
+60.4%
Accounts Receivable
$9.89K
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-53.64%
N/A
Return on Invested Capital
-60.16%
N/A
Free Cash Flow
$714.76K
+47.2%
Operating Cash Flow
$714.76K
+47.2%